China Construction Bank
- Collected applications
- 2
- Share of collected applications with IPC
- 0.2%
Coverage is incomplete; counts and shares describe only the collected subset.
View China Construction Bank publications in this fieldCompany patentsCompare
HEAD TO HEAD
Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.
This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.
Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.
China Construction Bank: Applicant names included in these statistics — CHINA CONSTRUCTION BANK CORPReviewed names not covered — CHINA CONSTRUCTION BANK CORPORATION · 中国建设银行股份有限公司
Eli Lilly: Applicant names included in these statistics — ELI LILLY AND CO · ELI LILLY AND COMPANY USA · LILLY CO ELIReviewed names not covered — ELI LILLY AND COMPANY
Meta: Applicant names included in these statistics — FACEBOOK INC · META PLATFORMS INC · META PLATFORMS TECH LLCReviewed names not covered — FACEBOOK TECHNOLOGIES LLC · FACEBOOK, INC. · META PLATFORMS TECHNOLOGIES , LLC · META PLATFORMS TECHNOLOGIES LLC · META PLATFORMS TECHNOLOGIES, LLC · META PLATFORMS TECHNOLOGIES, LLC. · META PLATFORMS, INC. · OCULUS VR LLC
China Construction Bank
Eli Lilly
Meta
China Construction Bank × Eli Lilly
China Construction Bank × Meta
Eli Lilly × Meta
The 12 fields with the largest combined share. Share shows structure; count shows scale.
| Technology field | China Construction Bank / Eli Lilly / Meta |
|---|---|
| Computer technology | 72.3% 0.6% 49.3% |
| Pharmaceuticals | 0% 68.5% 0% |
| IT methods for management | 40.7% 0.2% 2.1% |
| Biotechnology | 0% 39.9% 0% |
| Optics | 0% 0% 36.7% |
| Digital communication | 17.9% 0.1% 12.4% |
| Organic fine chemistry | 0% 25.8% 0% |
| Medical technology | 0.4% 17.6% 2.5% |
| Audio-visual technology | 0.2% 0.1% 17% |
| Telecommunications | 0.5% 0% 5.5% |
| Electrical machinery, apparatus, energy | 0% 0% 5.4% |
| Measurement | 0% 1% 4.1% |
Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.
Coverage is incomplete; counts and shares describe only the collected subset.
View China Construction Bank publications in this fieldCoverage is incomplete; counts and shares describe only the collected subset.
View Eli Lilly publications in this fieldCoverage is incomplete; counts and shares describe only the collected subset.
View Meta publications in this fieldOne application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.
The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.
Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.
| Period | China Construction Bank | Eli Lilly | Meta |
|---|---|---|---|
| 2025-01 | ≥199 (partial coverage) | ≥118 (partial coverage) | ≥116 (partial coverage) |
| 2025-02 | ≥228 (partial coverage) | ≥121 (partial coverage) | ≥146 (partial coverage) |
| 2025-03 | ≥163 (partial coverage) | ≥158 (partial coverage) | ≥163 (partial coverage) |
| 2025-04 | ≥52 (partial coverage) | ≥110 (partial coverage) | ≥153 (partial coverage) |
| 2025-05 | ≥15 (partial coverage) | ≥134 (partial coverage) | ≥142 (partial coverage) |
| 2025-06 | ≥16 (partial coverage) | ≥140 (partial coverage) | ≥124 (partial coverage) |
| 2025-07 | ≥22 (partial coverage) | ≥138 (partial coverage) | ≥123 (partial coverage) |
| 2025-08 | ≥16 (partial coverage) | ≥134 (partial coverage) | ≥130 (partial coverage) |
| 2025-09 | ≥10 (partial coverage) | ≥132 (partial coverage) | ≥94 (partial coverage) |
| 2025-10 | ≥11 (partial coverage) | ≥155 (partial coverage) | ≥153 (partial coverage) |
| 2025-11 | ≥67 (partial coverage) | ≥140 (partial coverage) | ≥102 (partial coverage) |
| 2025-12 | ≥307 (partial coverage) | ≥122 (partial coverage) | ≥99 (partial coverage) |
Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.
Publication timing follows examination and publication cycles, not R&D intensity.
What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.
What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.
Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.